Skip to main content
OpenTrials
Completed

NCT Number: NCT03896243

Serum Antimullerian Hormone Levels in Patients Who Underwent Uterine Artery Ligation

Investigators would like to see the amh values after uterine artery ligation

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Uterine Artery Ligation Dystocia Female Urogenital Diseases and Pregnancy Complications Obstetric Labor Complications Ovarian Reserve Pregnancy Complications Urogenital Diseases Uterine Inertia

Age range

18 year–35 year

Sex eligibility

Female

Study type

Observational

Primary location

Pinar Yalcin Bahat

Istanbul, İ̇stanbul, 34000, Turkey (Türkiye)

About this study

Group/cohort:

Uterine artery ligation (UAL) Investigators would like to invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section.

Participants would be evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Control Group:

Investigators would like to invite the patients to the hospital at least 6 months after C-section who delivered baby without any complication.

Participants would be also evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age 18- 35 years
  • no systemic or endocrine diseases
  • patients who had uterine artery ligation due to atony
  • healthy postpartum patients as controls

Exclusion criteria

  • patients with PCOS
  • Pregnancy with IVF or oosit donation
  • Patients with endocrinopathy, diseases which require radiotherapy and chemotherapy etc.
  • Patients with BMI >40

Treatment and study plan

Uterine artery ligation (UAL)

Diagnostic Test

Uterine artery ligation (UAL) We will invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section.

They will evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Primary outcomes

  1. 1.ovarian reserve in patients with uterine artery ligation

    Time frame: 12 months

    calculation of ovarian reserve with amh (ng/ml) after uterine artery ligation due to uterine atony

Sponsors and collaborators

Lead sponsor

Kanuni Sultan Suleyman Training and Research Hospital

Other

Registry information

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Mar 29, 2019
Registry last updated
Mar 29, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.